Predictive factors of heart failure in acute coronary syndrome: Institutional cross-sectional study.

ASC Heart failure NSTEMI STEMI

Journal

Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 22 06 2022
revised: 31 07 2022
accepted: 31 07 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

Heart failure complicating acute coronary syndrome (ACS) remains a challenge because it is associated with a high risk of mortality at 1 year.Our objective is to highlight the factors frequently associated with heart failure following an ACS and thus deduce the predictive factors for the occurrence of heart failure. ACS patients who were managed between 01/01/2021 to 06/30/2021 at the authors' institution were included retrospectively in the analysis. One hundred twenty-one patients (121) included. Eighty-seven were males (72%), and the mean age was 59.4 ± 8.8. Most patients were smokers (58.7%),40% were diabetic, and 40.5% were hypertensive. Dyslipidemia was found in 37.2% of cases. 75% of patients were admitted for STEMI, and 25% for NSTEMI. The majority of patients (67.5%) were admitted out of time. The anterior electrical territory was found as a factor in the occurrence of heart failure (OR = 5.47, 95% CI (2.16-15.26), P = 0.0005). Among the patients who presented a heart failure, 64% had an LVEF <40%, and only 3% with an LVEF >50% (P < 0.001). Also, 76% had a Wall Motion Index Score (WMSI) of 1.5 (P < 0.001). Angioplasty was the treatment of choice in 65%, aortocoronary bypass in 7% of cases, and medical treatment alone, associated or not with ischemia/viability tests in 28% of cases. Patients admitted out of time (>12 h) were found to be a factor in the occurrence of HF (OR = 3.31,95% CI (1.21-10,60), P = 0.02). The outcome was favorable in 93% of cases. We observed 9 cases of complications including 4 deaths from cardiogenic, septic, and hemorrhagic shock. This study allows us to identify patients at risk of developing heart failure and patients with a more reserved prognosis. Besides, our findings will allow our peers and colleagues to be able to detect early these factors and optimize adequate management to avoid heart failure.

Sections du résumé

Background UNASSIGNED
Heart failure complicating acute coronary syndrome (ACS) remains a challenge because it is associated with a high risk of mortality at 1 year.Our objective is to highlight the factors frequently associated with heart failure following an ACS and thus deduce the predictive factors for the occurrence of heart failure.
Methods UNASSIGNED
ACS patients who were managed between 01/01/2021 to 06/30/2021 at the authors' institution were included retrospectively in the analysis.
Results UNASSIGNED
One hundred twenty-one patients (121) included. Eighty-seven were males (72%), and the mean age was 59.4 ± 8.8. Most patients were smokers (58.7%),40% were diabetic, and 40.5% were hypertensive. Dyslipidemia was found in 37.2% of cases. 75% of patients were admitted for STEMI, and 25% for NSTEMI. The majority of patients (67.5%) were admitted out of time. The anterior electrical territory was found as a factor in the occurrence of heart failure (OR = 5.47, 95% CI (2.16-15.26), P = 0.0005). Among the patients who presented a heart failure, 64% had an LVEF <40%, and only 3% with an LVEF >50% (P < 0.001). Also, 76% had a Wall Motion Index Score (WMSI) of 1.5 (P < 0.001). Angioplasty was the treatment of choice in 65%, aortocoronary bypass in 7% of cases, and medical treatment alone, associated or not with ischemia/viability tests in 28% of cases. Patients admitted out of time (>12 h) were found to be a factor in the occurrence of HF (OR = 3.31,95% CI (1.21-10,60), P = 0.02). The outcome was favorable in 93% of cases. We observed 9 cases of complications including 4 deaths from cardiogenic, septic, and hemorrhagic shock.
Conclusions UNASSIGNED
This study allows us to identify patients at risk of developing heart failure and patients with a more reserved prognosis. Besides, our findings will allow our peers and colleagues to be able to detect early these factors and optimize adequate management to avoid heart failure.

Identifiants

pubmed: 36147130
doi: 10.1016/j.amsu.2022.104332
pii: S2049-0801(22)01092-5
pmc: PMC9486600
doi:

Types de publication

Journal Article

Langues

eng

Pagination

104332

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

Not applicable; the authors declare that they have no competing interests.

Références

J Clin Epidemiol. 1995 Oct;48(10):1197-205
pubmed: 7561981
J Am Coll Cardiol. 2002 Oct 16;40(8):1389-94
pubmed: 12392826
Am Heart J. 1997 Jun;133(6):663-73
pubmed: 9200394
J Am Heart Assoc. 2016 Jan 07;5(1):
pubmed: 26744379
Eur J Heart Fail. 2007 Sep;9(9):879-85
pubmed: 17594912
Int J Surg. 2021 Dec;96:106165
pubmed: 34774726
Eur Heart J. 2008 Mar;29(6):748-56
pubmed: 18308687
Int J Cardiol Heart Vasc. 2019 Mar 28;23:100350
pubmed: 30976655
Am Heart J. 2006 Feb;151(2):419-25
pubmed: 16442909
Am J Epidemiol. 2003 Jun 15;157(12):1101-7
pubmed: 12796046
Eur J Heart Fail. 2008 Aug;10(8):780-5
pubmed: 18599344
Circulation. 1986 Mar;73(3):503-10
pubmed: 3948357
Am Heart J. 1999 Jan;137(1):49-58
pubmed: 9878936
Eur Heart J. 2011 Jul;32(13):1640-8
pubmed: 21398642
Am J Cardiol. 1998 Mar 1;81(5):538-44
pubmed: 9514446
J Am Coll Cardiol. 2003 Oct 15;42(8):1446-53
pubmed: 14563590
Circulation. 2004 Feb 3;109(4):494-9
pubmed: 14744970
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Am Heart J. 2011 Oct;162(4):663-70
pubmed: 21982658
Circulation. 1993 Mar;87(3):755-63
pubmed: 8443896
Circulation. 2008 Nov 11;118(20):2057-62
pubmed: 18955667
J Am Soc Echocardiogr. 2017 May;30(5):431-443.e2
pubmed: 28477781
J Am Coll Cardiol. 1999 Nov 1;34(5):1378-87
pubmed: 10551682
Eur Heart J. 2007 Jul;28(14):1709-16
pubmed: 17556348
J Am Coll Cardiol. 2007 Nov 27;50(22):2173-95
pubmed: 18036459

Auteurs

Abakar Bachar (A)

Service de Cardiologie B, CHU IBN SINA, Rabat, Morocco.
Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco.

Fatima Azzahra Benmessaoud (FA)

Service de Cardiologie B, CHU IBN SINA, Rabat, Morocco.
Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco.

Abdoulaye Diatta (A)

Service de Cardiologie B, CHU IBN SINA, Rabat, Morocco.
Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco.

Hassan Fadoum (H)

Service de Cardiologie B, CHU IBN SINA, Rabat, Morocco.
Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco.

Abbas Ermilo Haroun (AE)

Laboratory of Public Health, Rabat, Morocco.
Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco.

Latifa Oukerraj (L)

Service de Cardiologie B, CHU IBN SINA, Rabat, Morocco.
Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco.

Mohammed Cherti (M)

Service de Cardiologie B, CHU IBN SINA, Rabat, Morocco.
Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco.

Classifications MeSH